BMRN: Robust growth, pipeline expansion, and global execution position the business for sustained success
Metabolic and skeletal franchises are driving strong revenue growth, with VOXZOGO and Amicus products expanding globally. R&D pipeline advances include promising hypochondroplasia data, new deals, and upcoming readouts for BMN 333, BMN 351, and FSGS. Strategic settlements and commercial execution s…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.